BridgeBio Pharma BBIO
NASDAQ BBIO
$67.25 +0.34 (+0.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

BridgeBio Pharma (BBIO) Change in Accured Expenses (2018 - 2026)

Updated

BridgeBio Pharma (BBIO) posted Change in Accured Expenses of $11.72 million for Q2 2026, up 214.6% from $3.73 million a year earlier.

Analysis

BridgeBio Pharma (BBIO) Change in Accured Expenses (2018 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Change in Accured Expenses at BridgeBio Pharma was $12.9 million, up 32.7% year-over-year; for FY2025, it came in at $23.02 million, up 35.5% from FY2024.

  • Annual Change in Accured Expenses shows a five-year compound annual growth rate of 21.8% (FY2020 to FY2025).
  • In prior years, BridgeBio Pharma's Change in Accured Expenses was $16.99 million in FY2024 (+117.7%), $7.8 million in FY2023, -$7.73 million in FY2022 and $14.16 million in FY2021 (+64.9%).
  • Quarterly Change in Accured Expenses has run from a low of -$37.48 million in Q1 2026 to a high of $19.81 million in Q4 2025 over five years.
  • On a year-over-year basis, Change in Accured Expenses increased in four of the last six quarters, with growth averaging 62.8%.
  • The strongest year-over-year quarter for Change in Accured Expenses in the past five years was Q4 2023, with growth of 758.4%; the weakest was Q3 2022, with a decline of 93.1%.
  • According to Business Quant data, Change in Accured Expenses for the three prior quarters was -$37.48 million (Q1 2026), $19.81 million (Q4 2025) and $18.85 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 2.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 1.20 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 338.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 BridgeBio Pharma 13.07 Bn 10.18 Bn 228.63 Mn 11.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.72 Mn
Mar 31, 2026 -37.48 Mn
Dec 31, 2025 19.81 Mn
Sep 30, 2025 18.85 Mn
Jun 30, 2025 3.73 Mn
Mar 31, 2025 -19.36 Mn
Dec 31, 2024 11.41 Mn
Sep 30, 2024 13.96 Mn
Jun 30, 2024 6.59 Mn
Mar 31, 2024 -14.97 Mn
Dec 31, 2023 11.96 Mn
Sep 30, 2023 6.92 Mn
Jun 30, 2023 7.30 Mn
Mar 31, 2023 -18.37 Mn
Dec 31, 2022 1.39 Mn
Sep 30, 2022 280,000.00
Jun 30, 2022 7.47 Mn
Mar 31, 2022 -16.88 Mn
Dec 31, 2021 18.61 Mn
Sep 30, 2021 4.05 Mn
API Access

BridgeBio Pharma Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=BBIO&period=max&api_key=YOUR_API_KEY